Published in Br J Pharmacol on February 11, 2008
How does the urothelium affect bladder function in health and disease? ICI-RS 2011. Neurourol Urodyn (2012) 1.02
Porcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release. Front Pharmacol (2011) 0.93
Unique properties of muscularis mucosae smooth muscle in guinea pig urinary bladder. Am J Physiol Regul Integr Comp Physiol (2011) 0.90
An exploration of the control of micturition using a novel in situ arterially perfused rat preparation. Front Neurosci (2011) 0.83
Immunocytochemical characterisation of cultures of human bladder mucosal cells. BMC Urol (2011) 0.81
Bladder smooth muscle strip contractility as a method to evaluate lower urinary tract pharmacology. J Vis Exp (2014) 0.77
Luminal DMSO: effects on detrusor and urothelial/lamina propria function. Biomed Res Int (2014) 0.77
Enhanced urothelial ATP release and contraction following intravesical treatment with the cytotoxic drug, doxorubicin. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.76
Gene expression of muscarinic, tachykinin, and purinergic receptors in porcine bladder: comparison with cultured cells. Front Pharmacol (2013) 0.76
Phasic contractions in urinary bladder from juvenile versus adult pigs. PLoS One (2013) 0.75
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism? J Physiol (1997) 3.43
A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol (1984) 2.30
Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A (2001) 2.17
Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther (1995) 1.96
Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A (1988) 1.87
Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol (2005) 1.77
Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol (2000) 1.69
Tachykinins and tachykinin receptors: a growing family. Life Sci (2004) 1.63
The role of the human bladder lamina propria myofibroblast. BJU Int (2003) 1.57
Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol (1998) 1.55
Non-neuronal cholinergic system in human bladder urothelium. Urology (2006) 1.31
Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am J Pathol (2000) 1.26
Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol (2006) 1.20
Characteristics of adenosine triphosphate [corrected] release from porcine and human normal bladder. J Urol (2004) 1.15
Structural characterization of myofibroblasts in the bladder. BJU Int (2006) 1.02
Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest (1997) 1.01
Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology (2004) 1.01
Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept (2001) 1.00
Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells. Cell Tissue Res (2006) 0.98
Contractile effects of some polypeptides on the isolated urinary bladder of guinea-pig, rabbit, and rat. Acta Pharmacol Toxicol (Copenh) (1982) 0.90
Tachykinins and tachykinin receptors: effects in the genitourinary tract. Life Sci (2005) 0.89
Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin Ther Targets (2003) 0.87
Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Regul Pept (2001) 0.86
Investigation of neurokinin-2 and -3 receptors in the human and pig bladder. BJU Int (2003) 0.85
Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder. J Urol (2000) 0.84
Characterization of tachykinin NK2 receptors in human urinary bladder. J Urol (1995) 0.82
Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder. J Pharmacol Exp Ther (1996) 0.80
Enhancement of neurokinin A-induced smooth muscle contraction in human urinary bladder by mucosal removal and phosphoramidon: relationship to peptidase inhibition. Eur J Pharmacol (2002) 0.77
Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (1988) 8.56
Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience (1996) 1.78
Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol (2000) 1.69
Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. J Physiol (2007) 1.57
5-Hydroxytryptamine-induced potentiation of cholinergic responses to electrical field stimulation in pig detrusor muscle. BJU Int (2000) 1.38
Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science (1984) 1.26
Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretch. Br J Pharmacol (2009) 1.12
Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacol Exp Ther (1986) 1.12
Which muscarinic receptor is important in the bladder? World J Urol (2001) 1.06
The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro. Br J Pharmacol (2000) 1.06
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Br J Pharmacol (1999) 1.05
Tachykinin receptors: a radioligand binding perspective. J Neurochem (1993) 1.04
Roles of neuronal NK1 and NK3 receptors in synaptic transmission during motility reflexes in the guinea-pig ileum. Br J Pharmacol (1998) 1.03
The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes. Br J Pharmacol (1997) 1.03
Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol (2002) 0.96
Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder. Eur J Pharmacol (1986) 0.96
Antagonism of vasoconstrictor responses by exercise in the gracilis muscle of the dog. J Pharmacol Exp Ther (1973) 0.94
Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung. Mol Pharmacol (1992) 0.92
Distinct differences in tachykinin gene expression in ulcerative colitis, Crohn's disease and diverticular disease: a role for hemokinin-1? Neurogastroenterol Motil (2011) 0.91
The rat submaxillary gland contains predominantly P-type tachykinin binding sites. Peptides (1986) 0.87
Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder. Auton Autacoid Pharmacol (2006) 0.87
Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides (1987) 0.86
M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol (2000) 0.86
Localization of muscarinic receptors M1R, M2R and M3R in the human colon. Neurogastroenterol Motil (2010) 0.86
Investigation of neurokinin-2 and -3 receptors in the human and pig bladder. BJU Int (2003) 0.85
Comparison of the effects of neuropeptide K and neuropeptide gamma with neurokinin A at NK2 receptors in the hamster urinary bladder. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.85
Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens. Br J Pharmacol (1995) 0.85
Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus. J Pharmacol Exp Ther (1994) 0.85
Actions of neurotensin and (Gln4)-neurotensin on isolated tissues. Acta Pharmacol Toxicol (Copenh) (1977) 0.85
Characterization of tachykinin NK2 receptors in human urinary bladder. J Urol (1995) 0.82
Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart. Br J Pharmacol (1990) 0.82
[125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain. Peptides (1990) 0.81
Alpha 1B-adrenoceptor subtype mediating the phenylephrine-induced contractile response in rabbit corpus cavernosum penis. Jpn J Pharmacol (1996) 0.81
Characterization of the alpha1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter. Br J Pharmacol (2008) 0.81
Relaxant effects of potassium-channel openers on normal and hyper-reflexic detrusor muscle. Br J Urol (1997) 0.81
Autoradiographic demonstration of endothelium-dependent 125I-Bolton-Hunter substance P binding to dog carotid artery. Eur J Pharmacol (1986) 0.81
The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats. Br J Pharmacol (1994) 0.81
Mammalian tachykinins stimulate rat uterus by activating NK-2 receptors. Peptides (1993) 0.81
Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias. Eur J Pharmacol (1991) 0.81
Potential therapeutic targets for treatment of the overactive bladder. World J Urol (2001) 0.80
Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder. J Pharmacol Exp Ther (1996) 0.80
Cardiovascular and metabolic actions of neurotensin and (Gln4)-Neurotensin. Acta Physiol Scand (1976) 0.80
The influence of 17-beta-oestradiol and the natural oestrous cycle on alpha-adrenoceptor-mediated responses of the cardiovascular system in the rat. J Pharm Pharmacol (1995) 0.80
Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptors. J Pept Res (1998) 0.80
Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.79
Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus. J Pharmacol Exp Ther (1993) 0.79
Pharmacology of the internal anal sphincter and its relevance to faecal incontinence. Auton Autacoid Pharmacol (2009) 0.79
Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colon. Clin Exp Pharmacol Physiol (2000) 0.79
Binding and functional potency of neurokinin A analogues in the rat fundus: A structure-activity study. Pharmacology (1999) 0.79
Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium/lamina propria of the pig bladder. Auton Autacoid Pharmacol (2012) 0.79
The relationship between in vivo emptying of the gallbladder, biliary pain, and in vitro contractility of the gallbladder in patients with gallstones: is biliary colic muscular in origin? Scand J Gastroenterol (1999) 0.79
Distinct binding sites for substance P and neurokinin A (substance K): co-transmitters in rat brain. Peptides (1985) 0.79
Sensory nerves play an efferent role in the function of the arterioles, but not the dilator muscle, of the rat iris. J Auton Nerv Syst (1996) 0.79
Serotonin-induced potentiation of cholinergic responses to electrical field stimulation in normal and neurogenic overactive human detrusor muscle. BJU Int (2004) 0.78
The autoradiographic distribution of substance P binding sites in guinea-pig vas deferens is altered by capsaicin pretreatment. Eur J Pharmacol (1989) 0.78
Active relaxation of human gallbladder muscle is mediated by ATP-sensitive potassium channels. Digestion (2002) 0.78
Characterization of the alpha 1-adrenoceptors of the rat prostate gland. J Pharm Pharmacol (1993) 0.78
Alpha(1A/L)-adrenoceptors mediate contraction of the circular smooth muscle of the pig urethra. Auton Autacoid Pharmacol (2006) 0.78
Potentiation of alpha-adrenoceptor-mediated responses following chronic beta-adrenoceptor stimulation in the rat heart. Br J Pharmacol (1993) 0.78
Transient elevation of cardiac beta-adrenoceptor responsiveness and receptor number in the streptozotocin-diabetic rat. J Auton Pharmacol (1992) 0.78
Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide. Toxicol In Vitro (2013) 0.78
Differential sensitivity to phenoxybenzamine alkylation among types of neurokinin binding sites. Neuropeptides (1987) 0.78
Ranakinin: a novel NK1 tachykinin receptor agonist isolated with neurokinin B from the brain of the frog Rana ridibunda. J Neurochem (1991) 0.78
Diabetes-induced changes in cardiac beta-adrenoceptor responsiveness: effects of aldose reductase inhibition with ponalrestat. Br J Pharmacol (1991) 0.78
A novel substance P binding site in bovine adrenal medulla. Neurosci Lett (1990) 0.78
Autoradiographic localization of substance P binding sites in rat footpad skin. Neurosci Lett (1989) 0.78
Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. Eur J Pharmacol (1990) 0.77
Demonstration of 5-HT(3) receptor function and expression in the mouse bladder. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.77
Use of selective agonists and antagonists to characterize tachykinin receptors mediating airway responsiveness in anaesthetized guinea-pigs. Pulm Pharmacol (1994) 0.77
Tachykinin receptors and non-cholinergic bronchoconstriction in the anaesthetized guinea-pig. Clin Exp Pharmacol Physiol (1996) 0.77
Lack of neuropeptide Y receptor detection in human bladder and prostate. BJU Int (2000) 0.77
Effect of contraceptive steroid and enalapril treatment of systolic blood pressure and plasma renin-angiotensin in the rat. Clin Exp Hypertens (1994) 0.77
Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon. Br J Pharmacol (1999) 0.77
Characterization of the tachykinin NK2 receptor subtype in the rabbit pulmonary artery. Peptides (1992) 0.77
Angiotensin II in child urinary bladder: functional and autoradiographic studies. BJU Int (2000) 0.77
The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptor subtypes in the rat. J Auton Pharmacol (2001) 0.77
GAP-43 immunoreactivity of subepithelial and detrusor muscle nerve fibres in patients with refractory idiopathic detrusor overactivity. Neurourol Urodyn (2005) 0.77
Cardiovascular effects of amphibian and mammalian tachykinins in the toad, Bufo marinus. Neuropeptides (1993) 0.77
Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats. Clin Exp Pharmacol Physiol (1990) 0.76
The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat. J Pharm Pharmacol (2000) 0.76
Receptor binding profile of neuropeptide gamma and its fragments: comparison with the nonmammalian peptides carassin and ranakinin at three mammalian tachykinin receptors. Peptides (1993) 0.76
Autoradiographic distribution of substance K binding sites in rat gastrointestinal tract: a comparison with substance P. Eur J Pharmacol (1984) 0.76
Two classes of binding sites for [3H]substance P in rat cerebral cortex. Brain Res (1993) 0.76
Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality. Biochem Pharmacol (2001) 0.76
Effects of exercise metabolites on adrenergic vasoconstriction in the gracilis muscle of the dog. J Pharmacol Exp Ther (1975) 0.76
Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10). Neuropeptides (1994) 0.76
Comparative effects of adrenaline and felypressin (octapressin) on consecutive sections of the vascular bed in canine adipose tissue. Acta Physiol Scand (1977) 0.76
In vitro contractility of stimulated and non-stimulated human gallbladder muscle. Neurogastroenterol Motil (1996) 0.76
A novel, selective radioligand, [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10), for the tachykinin NK-2 receptor. Regul Pept (1993) 0.76
Autoradiographic localization and characterization of substance P binding in dog kidney. Eur J Pharmacol (1987) 0.76
Characterization of tachykinin receptors mediating bronchomotor and vasodepressor responses to neuropeptide gamma and substance P in the anaesthetized rabbit. Pulm Pharmacol Ther (1998) 0.76
Structure-activity studies at the rat tachykinin NK2 receptor: effect of substitution at position 5 of neurokinin A. J Pept Res (1999) 0.76
In vitro responses of gallbladder muscle from patients with acalculous biliary pain. Digestion (2000) 0.76
Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon. J Pharmacol Exp Ther (2001) 0.76
A modified in vitro technique to evaluate human detrusor muscle. Br J Urol (1997) 0.75
Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut. Biochem J (1992) 0.75
An investigation of tachykinin NK2 receptor subtypes in the rat. Eur J Pharmacol (1998) 0.75
Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies. Br J Pharmacol (1992) 0.75
Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens. Auton Autacoid Pharmacol (2015) 0.75
The activity of non-steroidal anti-inflammatory drugs in the rat mesenteric vasculature. J Pharm Pharmacol (1986) 0.75